Bitte aktiviere Javascript und schalte etwaige Werbeblocker ab

Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

EQS-News: DEFENCE’S ACCUTOX BOOSTS AND SYNERGIZES WITH IMMUNE CHECKPOINT INHIBITORS

EQS-News: DEFENCE’S ACCUTOX BOOSTS AND SYNERGIZES WITH IMMUNE CHECKPOINT INHIBITORS

EQS-News: DEFENCE’S ACCUTOX BOOSTS AND SYNERGIZES WITH IMMUNE CHECKPOINT INHIBITORS

0

Partners Group to acquire majority stake in FairJourney Biologics, a leading antibody discovery Contract Research OrganizationPhoto, wide shot, wide-angle lens, Private equity firm, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/11edc0a6-edfc-46d1-baee-abd4f510abd1.png

Partners Group to acquire majority stake in FairJourney Biologics, a leading antibody discovery Contract Research Organization

Partners Group to acquire majority stake in FairJourney Biologics, a leading antibody discovery Contract Research Organization

0

EQS-News: Eighth and largest acquisition in 2024: Mutares has signed an agreement to acquire Serneke Sverige from Serneke Group: https://upload.wikimedia.org/wikipedia/commons/thumb/c/c3/MUTARES.png/800px-MUTARES.png

EQS-News: Eighth and largest acquisition in 2024: Mutares has signed an agreement to acquire Serneke Sverige from Serneke Group

EQS-News: Eighth and largest acquisition in 2024: Mutares has signed an agreement to acquire Serneke Sverige from Serneke Group

0

EQS-News: Nordex Group receives order from Spain for almost 124 MW Photo, wide shot, wide-angle lens, Construction equipment, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/96af5505-e3c8-4496-bbb7-e4a5eba91e77.png

EQS-News: Nordex Group receives order from Spain for almost 124 MW

EQS-News: Nordex Group receives order from Spain for almost 124 MW

0

Lonza Welcomes New Group Chief Executive Officer Wolfgang WienandPhoto, wide shot, wide-angle lens, soft focus, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D

Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand

Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand

0

EQS-News: VIB Vermögen AG realizes value

EQS-News: VIB Vermögen AG realizes value

EQS-News: VIB Vermögen AG realizes value

0

Aperam update on Q2 2024 market & financial trends Photo, wide shot, wide-angle lens, Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png

Aperam update on Q2 2024 market & financial trends

Aperam update on Q2 2024 market & financial trends

0

EQS-News: Formycon receives FDA approval for FYB203/AHZANTIVE®1) (aflibercept-mrbb), a biosimilar to Eylea®2)Photo, wide shot, wide-angle lens, soft focus, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D

EQS-News: Formycon receives FDA approval for FYB203/AHZANTIVE®1) (aflibercept-mrbb), a biosimilar to Eylea®2)

EQS-News: Formycon receives FDA approval for FYB203/AHZANTIVE®1) (aflibercept-mrbb), a biosimilar to Eylea®2)

0

Silvio Denz publishes provisional interim result of the public tender offer to public shareholders of Lalique GroupPhoto, wide shot, wide-angle lens, Home appliance manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/5d70b6df-fa9b-4237-9702-39c36cb1d4f8.png

Silvio Denz publishes provisional interim result of the public tender offer to public shareholders of Lalique Group

Silvio Denz publishes provisional interim result of the public tender offer to public shareholders of Lalique Group

0

Acquisition Dejond Fastening NVPhoto, wide shot, wide-angle lens, Heavy machinery, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/c15253b0-7330-4605-a666-66954eaf6715.png

Acquisition Dejond Fastening NV

Acquisition Dejond Fastening NV

0

EQS-Adhoc: Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014

EQS-Adhoc: Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014

EQS-Adhoc: Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014

0

EQS-News: Endor AG makes progress in reorganizing the company in terms of management and financing

EQS-News: Endor AG makes progress in reorganizing the company in terms of management and financing

EQS-News: Endor AG makes progress in reorganizing the company in terms of management and financing

0

EQS-Adhoc: FDA grants approval for Eylea®1) biosimilar FYB203/AHZANTIVE®2) (aflibercept-mrbb)Photo, wide shot, wide-angle lens, soft focus, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D

EQS-Adhoc: FDA grants approval for Eylea®1) biosimilar FYB203/AHZANTIVE®2) (aflibercept-mrbb)

EQS-Adhoc: FDA grants approval for Eylea®1) biosimilar FYB203/AHZANTIVE®2) (aflibercept-mrbb)

0

EQS-News: The NAGA Group AG publishes 2023 Annual Report – 2024 Capital Markets Day in the wake of the merger with CAPEX.comPhoto, wide shot, wide-angle lens, soft focus, IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D

EQS-News: The NAGA Group AG publishes 2023 Annual Report – 2024 Capital Markets Day in the wake of the merger with CAPEX.com

EQS-News: The NAGA Group AG publishes 2023 Annual Report – 2024 Capital Markets Day in the wake of the merger with CAPEX.com

0

EQS-Adhoc: clearvise AG: Tion Renewables AG owns more than 25% of the shares

EQS-Adhoc: clearvise AG: Tion Renewables AG owns more than 25% of the shares

EQS-Adhoc: clearvise AG: Tion Renewables AG owns more than 25% of the shares

0

EQS-News: TTL publishes Annual Report 2023Photo, wide shot, wide-angle lens, soft focus, IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D

EQS-News: TTL publishes Annual Report 2023

EQS-News: TTL publishes Annual Report 2023

0

EQS-Adhoc: STRABAG SE shareholder MKAO Rasperia Trading Ltd. now also on EU sanctions listPhoto, wide shot, wide-angle lens, Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png

EQS-Adhoc: STRABAG SE shareholder MKAO Rasperia Trading Ltd. now also on EU sanctions list

EQS-Adhoc: STRABAG SE shareholder MKAO Rasperia Trading Ltd. now also on EU sanctions list

0

EQS-Adhoc: Endor AG: Extension of the standstill agreement by lending banks as part of the StaRUG proceedings

EQS-Adhoc: Endor AG: Extension of the standstill agreement by lending banks as part of the StaRUG proceedings

EQS-Adhoc: Endor AG: Extension of the standstill agreement by lending banks as part of the StaRUG proceedings

0

Funding Circle Plc: POS-Transaction in Own Shares

Funding Circle Plc: POS-Transaction in Own Shares

Funding Circle Plc: POS-Transaction in Own Shares

0

Fuller, Smith & Turner PLC: Transaction in own sharesPhoto, wide shot, wide-angle lens, Restaurant, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/6d1f34ee-79e7-4628-b30f-0a4597808d61.png

Fuller, Smith & Turner PLC: Transaction in own shares

Fuller, Smith & Turner PLC: Transaction in own shares

0

Xlife Sciences AG: Successful General Assembly and New Trading Hours on the Sparks Segment of SIX

Xlife Sciences AG: Successful General Assembly and New Trading Hours on the Sparks Segment of SIX

Xlife Sciences AG: Successful General Assembly and New Trading Hours on the Sparks Segment of SIX

0

The Annual General Meeting of Highlight Event and Entertainment AG adopts all proposals of the Board of DirectorsPhoto, wide shot, wide-angle lens, Retail store, neutral atmosphere, photo by Joe Cornish: https://img.theapi.app/temp/5574eb69-dc38-42f3-aadd-6163ac8bd4a8.png

The Annual General Meeting of Highlight Event and Entertainment AG adopts all proposals of the Board of Directors

The Annual General Meeting of Highlight Event and Entertainment AG adopts all proposals of the Board of Directors

0

EQS-Adhoc: 029 Group SE appoints Leon Sander as new managing director

EQS-Adhoc: 029 Group SE appoints Leon Sander as new managing director

EQS-Adhoc: 029 Group SE appoints Leon Sander as new managing director

0

EQS-News: Avemio AG published audited consolidated figures for 2023 – preliminary results confirmed

EQS-News: Avemio AG published audited consolidated figures for 2023 – preliminary results confirmed

EQS-News: Avemio AG published audited consolidated figures for 2023 – preliminary results confirmed

0

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 30 March 2024 and Notice of 2024 Annual General MeetingPhoto, wide shot, wide-angle lens, Hotel, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/d14bb504-852b-4d13-a69a-8cec9d4eb799.png

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 30 March 2024 and Notice of 2024 Annual General Meeting

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 30 March 2024 and Notice of 2024 Annual General Meeting

0